We are live on ! Find out more
IIM

Ipswich Investment Management Portfolio holdings

AUM $474M
1-Year Est. Return 35.58%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+35.58%
3 Year Est. Return
+92.81%
5 Year Est. Return
+126.14%
10 Year Est. Return
+1,334%
AUM
$414M
AUM Growth
+$11.5M
Cap. Flow
-$7.73M
Cap. Flow %
-1.87%
Top 10 Hldgs %
34.7%
Holding
195
New
9
Increased
25
Reduced
80
Closed
10

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$868K
2
UNP icon
Union Pacific
UNP
+$661K
3
PG icon
Procter & Gamble
PG
+$648K
4
MMM icon
3M
MMM
+$643K
5
PM icon
Philip Morris
PM
+$567K

Sector Composition

Rank Sector Weight
1 Technology 25.53%
2 Financials 13.19%
3 Healthcare 10.63%
4 Industrials 10.06%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTIS icon
26
Otis Worldwide
OTIS
$27.8B
$4.88M 1.18%
49,286
-165
-0.3% -$15.9K
TPL icon
27
Texas Pacific Land
TPL
$25.2B
$4.79M 1.16%
13,605
+870
+7% +$356K
AMGN icon
28
Amgen
AMGN
$224B
$4.62M 1.11%
16,529
-37
-0.2% -$10.5K
LLY icon
29
Eli Lilly
LLY
$1.08T
$4.49M 1.08%
5,765
+1,950
+51% +$1.52M
ASML icon
30
ASML
ASML
$691B
$4.49M 1.08%
5,603
+176
+3% +$126K
IBM icon
31
IBM
IBM
$225B
$3.99M 0.96%
13,522
-980
-7% -$252K
MRK icon
32
Merck
MRK
$322B
$3.75M 0.91%
47,412
-1,508
-3% -$120K
CCJ icon
33
Cameco
CCJ
$43B
$3.74M 0.9%
50,434
-6,175
-11% -$330K
IVV icon
34
iShares Core S&P 500 ETF
IVV
$902B
$3.43M 0.83%
5,520
-2
-0% -$1.15K
BIPC icon
35
Brookfield Infrastructure
BIPC
$4.92B
$3.4M 0.82%
81,652
-6,435
-7% -$248K
HON icon
36
Honeywell
HON
$72.9B
$3.28M 0.79%
14,930
-1,549
-9% -$314K
KO icon
37
Coca-Cola
KO
$372B
$2.92M 0.7%
41,233
-285
-0.7% -$20.3K
PEP icon
38
PepsiCo
PEP
$189B
$2.86M 0.69%
21,688
-2,130
-9% -$287K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.19T
$2.75M 0.66%
15,502
-250
-2% -$41.3K
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$134B
$2.5M 0.6%
5,608
+90
+2% +$41.5K
EMR icon
41
Emerson Electric
EMR
$91.7B
$2.43M 0.59%
18,249
-3,062
-14% -$351K
GE icon
42
GE Aerospace
GE
$382B
$2.21M 0.53%
8,583
NVS icon
43
Novartis
NVS
$294B
$2.19M 0.53%
18,127
-1,335
-7% -$150K
ABBV icon
44
AbbVie
ABBV
$442B
$2.18M 0.53%
11,738
-2,725
-19% -$506K
DUK icon
45
Duke Energy
DUK
$96.1B
$2.12M 0.51%
17,987
CCOI icon
46
Cogent Communications
CCOI
$554M
$2.12M 0.51%
43,890
+1,151
+3% +$58.4K
RTX icon
47
RTX Corp
RTX
$302B
$1.97M 0.48%
13,525
-740
-5% -$98.6K
LEU icon
48
Centrus Energy
LEU
$3.77B
$1.96M 0.47%
10,675
-155
-1% -$16.5K
ADP icon
49
Automatic Data Processing
ADP
$108B
$1.92M 0.46%
6,233
-48
-0.8% -$14.7K
MCD icon
50
McDonald's
MCD
$194B
$1.9M 0.46%
6,505

Similar funds

Ipswich Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Ipswich Investment Management held 195 positions worth $414M, up 2.9% from $403M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ipswich Investment Management's Q2 2025 filing shows 9 new, 25 increased, 80 reduced and 10 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 6,003 shares worth $1.82M. The largest sale was Thermo Fisher Scientific, an estimated $868K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Ipswich Investment Management's largest Q2 2025 buy was Vanguard Morningstar Total Stock Market ETF: 6,003 shares worth $1.82M.
  • Ipswich Investment Management added most to Eli Lilly in Q2 2025, an estimated $1.52M increase.
  • Ipswich Investment Management's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $868K.
  • Ipswich Investment Management fully exited Edwards Lifesciences in Q2 2025, selling an estimated $504K.
  • Ipswich Investment Management's ten largest holdings make up 35% of its $414M portfolio in Q2 2025.
  • Ipswich Investment Management opened 9 new positions and closed 10 in Q2 2025.
  • Ipswich Investment Management's portfolio value rose 2.9% quarter-over-quarter to $414M.

Based on Ipswich Investment Management's 13F filing for Q2 2025, filed 16 Jul 2025.